A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.
Baldwin, David S. a; Cooper, James A. b; Huusom, Anna K.T. b; Hindmarch, Ian c
International Clinical Psychopharmacology.
21(3):159-169, May 2006.
(Format: HTML, PDF)